CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance cancer treatment by developing nanoparticle-based libraries of immunotherapeutic biomolecules for use after surgery. It focuses on personalized medicine strategies to improve patient outcomes by targeting micrometastases and optimizing immune responses.
The basic concept of our proposal is to develop nanoparticle-based encapsulated libraries of different immunotherapeutic biomolecules for treatment after surgery as part of a novel cancer management strategy.
The current state-of-art for the management of cancer starts with surgery, after identification of an accessible tumour mass.
Surgery remains an effective treatment option for many types of cancer today and it is considered curative treatment for most solid tumours.
It forms part of a multi…
PERCUROS BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Delft
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Camerino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, LANDSHUT
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
